Prospective evaluation of pregnancy-associated plasma protein-A and outcomes in patients with acute coronary syndromes

Journal of the American College of Cardiology

Volumn 60, Issue 4, 2012, Pages 332-338

  Bonaca, Marc P ^a   Scirica, Benjamin M ^a   Sabatine, Marc S ^a   Jarolim, Petr ^a   Murphy, Sabina A ^a   Chamberlin, Janna S ^b   Rhodes, Daniel W ^b   Southwick, Paula C ^b   Braunwald, Eugene ^a   Morrow, David A ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b BECKMAN COULTER INC   (United States)

Author keywords

acute coronary syndrome(s); atherothrombosis; ischemia; metalloproteinase; PAPP A

Indexed keywords

PLACEBO; PREGNANCY ASSOCIATED PLASMA PROTEIN A; RANOLAZINE; TROPONIN I;

AGE; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONGESTIVE HEART FAILURE; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CREATININE CLEARANCE; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DYSLIPIDEMIA; FEMALE; HEART INFARCTION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NON ST SEGMENT ELEVATION ACUTE CORONARY SYNDROME; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RISK ASSESSMENT; SEX; SMOKING;

ACETANILIDES; ACUTE CORONARY SYNDROME; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CAUSE OF DEATH; ELECTROCARDIOGRAPHY; ENZYME INHIBITORS; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; PIPERAZINES; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A; PROGNOSIS; PROSPECTIVE STUDIES; RECURRENCE; RISK ASSESSMENT; SIGNAL PROCESSING, COMPUTER-ASSISTED; SURVIVAL ANALYSIS; TROPONIN;

EID: 84863977460     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2012.04.023     Document Type: Article

References (27)

1. L.S. Laursen, M.T. Overgaard, C.G. Nielsen Substrate specificity of the metalloproteinase pregnancy-associated plasma protein-A (PAPP-A) assessed by mutagenesis and analysis of synthetic peptides: substrate residues distant from the scissile bond are critical for proteolysis Biochem J 367 2002 31 40
2. P. Libby Inflammation in atherosclerosis Nature 420 2002 868 874
3. A. Bayes-Genis, C.A. Conover, M.T. Overgaard Pregnancy-associated plasma protein A as a marker of acute coronary syndromes N Engl J Med 345 2001 1022 1029
4. N.J. Wald, L. George, D. Smith, J.W. Densem, K. Petterson Serum screening for Down's syndrome between 8 and 14 weeks of pregnancy International Prenatal Screening Research Group Br J Obstet Gynaecol 103 1996 407 412
5. J.B. Lawrence, C. Oxvig, M.T. Overgaard The insulin-like growth factor (IGF)-dependent IGF binding protein-4 protease secreted by human fibroblasts is pregnancy-associated plasma protein-A Proc Natl Acad Sci U S A 96 1999 3149 3153
6. A. Bayes-Genis, R.S. Schwartz, D.A. Lewis Insulin-like growth factor binding protein-4 protease produced by smooth muscle cells increases in the coronary artery after angioplasty Arterioscler Thromb Vasc Biol 21 2001 335 341
7. J. Lund, Q.P. Qin, T. Ilva Circulating pregnancy-associated plasma protein a predicts outcome in patients with acute coronary syndrome but no troponin I elevation Circulation 108 2003 1924 1926
8. F.S. Apple, A.H. Wu, J. Mair Future biomarkers for detection of ischemia and risk stratification in acute coronary syndrome Clin Chem 51 2005 810 824
9. D.A. Morrow, B.M. Scirica, E. Karwatowska-Prokopczuk Evaluation of a novel anti-ischemic agent in acute coronary syndromes: design and rationale for the Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST-Elevation Acute Coronary Syndromes (MERLIN)-TIMI 36 trial Am Heart J 151 2006 1186.e1 1186.e9
10. D.A. Morrow, B.M. Scirica, E. Karwatowska-Prokopczuk Effects of ranolazine on recurrent cardiovascular events in patients with non-ST-elevation acute coronary syndromes: the MERLIN-TIMI 36 randomized trial JAMA 297 2007 1775 1783
11. R. Tertti, S. Wittfooth, P. Porela, K.E. Airaksinen, K. Metsarinne, K. Pettersson Intravenous administration of low molecular weight and unfractionated heparin elicits a rapid increase in serum pregnancy-associated plasma protein A Clin Chem 55 2009 1214 1217
12. E.M. Antman, M. Cohen, P.J. Bernink The TIMI risk score for unstable angina/non-ST elevation MI: a method for prognostication and therapeutic decision making JAMA 284 2000 835 842
13. F.E. Harrell Jr Harrell Miscellaneous Package for R 2008 3.7-0 http://biostat.mc. vanderbilt.edu/s/Hmisc Accessed August 1, 2011
14. B.M. Scirica, M.S. Sabatine, P. Jarolim Myeloperoxidase levels associated with risk of cardiovascular death and heart failure after non-ST elevation acute coronary syndrome J Am Coll Cardiol 51 2008 A218
15. B.M. Scirica, C.P. Cannon, M.S. Sabatine Concentrations of C-reactive protein and B-type natriuretic peptide 30 days after acute coronary syndromes independently predict hospitalization for heart failure and cardiovascular death Clin Chem 55 2009 265 273
16. B.M. Scirica, M.S. Sabatine, P. Jarolim Assessment of multiple cardiac biomarkers in non-ST-segment elevation acute coronary syndromes: observations from the MERLIN-TIMI 36 trial Eur Heart J 32 2011 697 705
17. A.T. Yan, P.G. Steg, G. Fitzgerald Recurrent ischemia across the spectrum of acute coronary syndromes: prevalence and prognostic significance of (re-)infarction and ST-segment changes in a large contemporary registry Int J Cardiol 145 2010 15 20
18. D.A. Morrow Cardiovascular risk prediction in patients with stable and unstable coronary heart disease Circulation 121 2010 2681 2691
19. K.A. Fox, O.H. Dabbous, R.J. Goldberg Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE) BMJ 333 2006 1091
20. R.H. Christenson National Academy of Clinical Biochemistry National academy of clinical biochemistry laboratory medicine practice guidelines for utilization of biochemical markers in acute coronary syndromes and heart failure Clin Chem 53 2007 545 546
21. D.A. Morrow, B.M. Scirica, M.S. Sabatine B-type natriuretic peptide and the effect of ranolazine in patients with non-ST-segment elevation acute coronary syndromes: observations from the MERLIN-TIMI 36 (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST Elevation Acute Coronary- Thrombolysis in Myocardial Infarction 36) trial J Am Coll Cardiol 55 2010 1189 1196
22. C. Heeschen, S. Dimmeler, C.W. Hamm Pregnancy-associated plasma protein-A levels in patients with acute coronary syndromes: comparison with markers of systemic inflammation, platelet activation, and myocardial necrosis J Am Coll Cardiol 45 2005 229 237
23. A.S. Jaffe, H. Katus Acute coronary syndrome biomarkers: the need for more adequate reporting Circulation 110 2004 104 106
24. D.A. Morrow, J.A. de Lemos Benchmarks for the assessment of novel cardiovascular biomarkers Circulation 115 2007 949 952
25. E. Conti, F. Andreotti, C. Zuppi Pregnancy-associated plasma protein a as predictor of outcome in patients with suspected acute coronary syndromes Circulation 109 2004 e211 e212 author reply e211-2
26. J.H. Lindeman, H. Abdul-Hussien, J.H. van Bockel, R. Wolterbeek, R. Kleemann Clinical trial of doxycycline for matrix metalloproteinase-9 inhibition in patients with an abdominal aneurysm: doxycycline selectively depletes aortic wall neutrophils and cytotoxic T cells Circulation 119 2009 2209 2216
27. T. Stulc, I. Malbohan, J. Malik, L. Fialova, J. Soukupova, R. Ceska Increased levels of pregnancy-associated plasma protein-A in patients with hypercholesterolemia: the effect of atorvastatin treatment Am Heart J 146 2003 E21